This article lays out what is actually known about how long hydroxychloroquine tablets remain fully potent, what happens chemically as they age, how to store and handle them correctly at home, and what a patient beginning or continuing treatment should realistically expect. Hydroxychloroquine, sold under the brand name Plaquenil and often abbreviated HCQ, is a well-established medication with decades of use, and the practical questions around it deserve straightforward, evidence-based answers rather than either alarm or false reassurance.
Where Hydroxychloroquine Comes From, and Why That Shapes Its Stability
Hydroxychloroquine sulfate is a synthetic descendant of a much older remedy. Chloroquine, developed in the 1930s and 1940s, was itself an outgrowth of centuries of use of quinine, the alkaloid isolated from the bark of the cinchona tree native to the Andes. Hydroxychloroquine was created in 1946 by adding a hydroxyl group to chloroquine's structure, producing a compound that was gentler on the gut and eyes at equivalent antimalarial doses. It is worth pausing on that lineage: a tree bark used empirically by South American and European physicians long before anyone understood parasitology eventually yielded, through careful chemistry, one of the more durable and versatile medicines in general use today. As a crystalline sulfate salt in solid tablet form, hydroxychloroquine is chemically robust, which is precisely why it has historically been suitable for national and military medical stockpiles meant to sit in storage for years.
Shelf Life: What the Label Date Actually Means
The expiration date printed on a manufacturer's bottle, typically 36 to 60 months from the date of manufacture, is set based on real-time and accelerated stability testing submitted to the FDA during drug approval. It reflects the point up to which the manufacturer guarantees full labeled potency and purity, not a hard cliff at which the tablet suddenly becomes ineffective.
Separately, the FDA and the Department of Defense have jointly run the Shelf Life Extension Program (SLEP) since 1986, testing sealed federal stockpile medications past their labeled expiration dates. A widely cited analysis of this program, published in the Journal of Pharmaceutical Sciences in 2006, examined well over 100 different stockpiled drug products and found that the large majority of tested lots remained within specification for potency and purity for years beyond their original expiration date, with average extensions measured in years rather than months. Solid, low-moisture crystalline tablets — the category hydroxychloroquine falls into — tend to be among the more stable formulations in this kind of long-term storage testing. That said, SLEP data is not published product-by-product for public use, and it applies to sealed bulk containers stored under controlled federal warehouse conditions, not to an opened prescription bottle sitting in a kitchen cabinet. It is informative context for how conservative expiration dating tends to be, not a personal guarantee.
There is also a practical wrinkle worth knowing: when a pharmacist repackages tablets from a manufacturer's bulk bottle into your amber prescription vial, U.S. compounding standards (USP <795>) generally require a beyond-use date of one year from dispensing, or the manufacturer's expiration date, whichever comes first. So the date on your prescription label may be considerably earlier than the tablet's actual chemical shelf life — that is a dispensing convention, not evidence the drug degrades within a year.
How to Store Hydroxychloroquine Tablets at Home
Hydroxychloroquine tablets, including standard 200 mg strength, are not fussy, but a few habits meaningfully protect potency and safety:
- Keep tablets at controlled room temperature, roughly 68–77°F (20–25°C); brief excursions to 59–86°F during travel are generally tolerated.
- Store in the original light-resistant container with the cap tightened; the bottle is designed to limit light exposure, which contributes to degradation over long periods.
- Avoid bathroom medicine cabinets — shower steam raises humidity and can degrade tablets or soften them over time.
- Never leave the bottle in a hot car, on a windowsill, or anywhere near direct sunlight for extended periods.
- Weekly pill organizers are fine for routine use, but tablets left exposed to air and light in an organizer for many weeks lose the protection of the original packaging.
- Compounded liquid suspensions, sometimes prepared for children or patients with feeding tubes, are far less stable than tablets and typically carry a beyond-use date of only weeks, often requiring refrigeration — follow the compounding pharmacy's label exactly rather than assuming tablet-level stability.
What Actually Happens When Hydroxychloroquine Degrades
Unlike a small number of older drugs known to form genuinely toxic breakdown products (tetracycline is the classic historical example), there is no well-documented case series showing hydroxychloroquine tablets becoming dangerous through ordinary aging. The realistic concern with an old bottle is not poisoning but a quiet loss of potency — the active drug content slowly falling below the labeled amount as moisture and light exposure accumulate. For someone taking hydroxychloroquine for malaria prevention on a single trip, a modest potency loss is a minor concern. For someone relying on it daily to keep lupus or rheumatoid arthritis under control, taking tablets that have lost meaningful potency could mean a disease flare that is easy to mistake for treatment failure rather than a storage problem. Visible signs — tablet discoloration, crumbling, a chalky texture, or an off odor — indicate humidity damage, and tablets showing any of these should be discarded regardless of the printed date.
What to Expect From Treatment
Hydroxychloroquine is FDA-approved for the prevention and treatment of malaria caused by susceptible Plasmodium species, and for rheumatoid arthritis and systemic and discoid lupus erythematosus. It is not FDA-approved for the prevention or treatment of COVID-19. It briefly held an Emergency Use Authorization for hospitalized COVID-19 patients in March 2020, which the FDA revoked in June 2020 after evidence — including the large randomized RECOVERY trial run by Oxford University and published in the New England Journal of Medicine in 2020 — showed no reduction in mortality among hospitalized patients. Anyone considering the drug for that purpose today should understand that the authorization was withdrawn and discuss the actual evidence, not assumptions, with their physician.
For its approved chronic uses, dosing is generally calculated by real body weight, with the American Academy of Ophthalmology's 2016 revised guidance recommending no more than about 5 mg/kg/day to limit the risk of retinal toxicity, a rare but serious long-term concern. Patients starting long-term therapy should expect a baseline eye examination, with annual screening typically beginning around the fifth year of use (sooner if kidney disease, certain other medications, or higher doses are involved). Nausea or mild stomach upset is common when starting and often improves when the tablet is taken with food. Benefits for lupus and rheumatoid arthritis build gradually — noticeable improvement can take weeks to a few months, which is worth knowing so early expectations are realistic.
Practical Guidance for Patients Who Depend on It Long-Term
The 2020 surge in interest in hydroxychloroquine for COVID-19 caused real, documented shortages that made it harder for some lupus and rheumatoid arthritis patients to fill their routine prescriptions, prompting public concern from rheumatology and lupus patient organizations at the time. The lesson for chronic users is straightforward: this is a maintenance medication for a real, ongoing disease, and continuity of supply matters. It is reasonable to ask your physician and pharmacy about a modest buffer — refilling before the bottle runs empty rather than waiting until the last dose — as a matter of ordinary preparedness for your own family's health, not as stockpiling that deprives others.
- Never share tablets. Dosing is individualized by weight and indication, and hydroxychloroquine overdose is a genuine medical emergency, capable of causing dangerous heart rhythm disturbances even in relatively small amounts.
- Keep the bottle stored up, away, and out of sight from children. A handful of adult tablets can be seriously toxic to a small child, and this class of drug is one of the more dangerous accidental pediatric ingestions on record.
- Do not flush unused tablets. Hydroxychloroquine is not on the FDA's list of medicines recommended for flushing; use a pharmacy take-back program, or if none is available, mix tablets with an undesirable substance like used coffee grounds, seal in a bag, and place in household trash.
Key takeaway: Hydroxychloroquine tablets are chemically stable and reliably potent when stored at room temperature away from light and moisture, and the greatest practical risks are quietly diminished potency from a truly old bottle, accidental ingestion by a child, and confusion about approved uses — all of which are avoidable with plain, informed handling and an honest conversation with your physician.